![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: XIRP2 |
Gene summary for XIRP2 |
![]() |
Gene information | Species | Human | Gene symbol | XIRP2 | Gene ID | 129446 |
Gene name | xin actin binding repeat containing 2 | |
Gene Alias | CMYA3 | |
Cytomap | 2q24.3 | |
Gene Type | protein-coding | GO ID | GO:0003007 | UniProtAcc | A4UGR9 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
129446 | XIRP2 | HTA11_7469_2000001011 | Human | Colorectum | AD | 1.62e-18 | 1.66e+00 | -0.0124 |
Page: 1 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0007015 | Colorectum | AD | actin filament organization | 167/3918 | 442/18723 | 1.65e-16 | 7.94e-14 | 167 |
GO:0045216 | Colorectum | AD | cell-cell junction organization | 80/3918 | 200/18723 | 5.57e-10 | 4.58e-08 | 80 |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
XIRP2 | SNV | Missense_Mutation | c.2648N>A | p.Pro883Gln | p.P883Q | A4UGR9 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-62-A46P-01 | Lung | lung adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | PD | |
XIRP2 | SNV | Missense_Mutation | c.210G>T | p.Met70Ile | p.M70I | A4UGR9 | protein_coding | tolerated_low_confidence(0.21) | benign(0.003) | TCGA-64-1679-01 | Lung | lung adenocarcinoma | Female | <65 | III/IV | Chemotherapy | cisplatin | SD | |
XIRP2 | SNV | Missense_Mutation | rs748864933 | c.5129G>A | p.Gly1710Asp | p.G1710D | A4UGR9 | protein_coding | deleterious(0) | probably_damaging(0.962) | TCGA-64-1679-01 | Lung | lung adenocarcinoma | Female | <65 | III/IV | Chemotherapy | cisplatin | SD |
XIRP2 | SNV | Missense_Mutation | c.1723N>A | p.Gln575Lys | p.Q575K | A4UGR9 | protein_coding | deleterious(0.03) | probably_damaging(0.96) | TCGA-64-5779-01 | Lung | lung adenocarcinoma | Male | <65 | III/IV | Chemotherapy | cisplatin | PD | |
XIRP2 | SNV | Missense_Mutation | novel | c.493N>T | p.Asp165Tyr | p.D165Y | A4UGR9 | protein_coding | deleterious_low_confidence(0) | possibly_damaging(0.891) | TCGA-64-5781-01 | Lung | lung adenocarcinoma | Female | <65 | I/II | Chemotherapy | cisplatin | PD |
XIRP2 | SNV | Missense_Mutation | novel | c.4094N>T | p.Ser1365Leu | p.S1365L | A4UGR9 | protein_coding | deleterious(0.02) | benign(0.063) | TCGA-64-5781-01 | Lung | lung adenocarcinoma | Female | <65 | I/II | Chemotherapy | cisplatin | PD |
XIRP2 | SNV | Missense_Mutation | novel | c.6797N>A | p.Ala2266Glu | p.A2266E | A4UGR9 | protein_coding | deleterious_low_confidence(0) | possibly_damaging(0.907) | TCGA-64-5781-01 | Lung | lung adenocarcinoma | Female | <65 | I/II | Chemotherapy | cisplatin | PD |
XIRP2 | SNV | Missense_Mutation | novel | c.4383G>T | p.Met1461Ile | p.M1461I | A4UGR9 | protein_coding | tolerated(1) | benign(0) | TCGA-64-5815-01 | Lung | lung adenocarcinoma | Male | >=65 | I/II | Chemotherapy | gemcitabine | CR |
XIRP2 | SNV | Missense_Mutation | c.4384G>T | p.Asp1462Tyr | p.D1462Y | A4UGR9 | protein_coding | deleterious(0) | probably_damaging(0.983) | TCGA-64-5815-01 | Lung | lung adenocarcinoma | Male | >=65 | I/II | Chemotherapy | gemcitabine | CR | |
XIRP2 | SNV | Missense_Mutation | c.8852N>T | p.Arg2951Leu | p.R2951L | A4UGR9 | protein_coding | deleterious(0) | probably_damaging(0.909) | TCGA-67-3771-01 | Lung | lung adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
129446 | XIRP2 | NA | atenolol | ATENOLOL |
Page: 1 |